AUL
AMGN icon

AlphaGrep UK Ltd’s Amgen AMGN Stock Holding History

AlphaGrep UK Ltd’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$251K Sell
714
-444
-38% -$158K 0.07% 596
2025
Q4 		$379K Buy
+1,158
New +$367K 0.13% 308

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaGrep UK Ltd's AMGN Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $158K and leaving 714 shares worth $251K. The position accounts for 0.07% of the portfolio, ranked #596.

AlphaGrep UK Ltd first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $379K in Q4 2025. 3,140 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • AlphaGrep UK Ltd held 714 shares of Amgen worth $251K as of Q1 2026.
  • AlphaGrep UK Ltd sold 444 Amgen shares in Q1 2026, an estimated $158K.
  • Amgen made up 0.07% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #596 holding.
  • AlphaGrep UK Ltd first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's Amgen position peaked at $379K in Q4 2025.
  • 3,140 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.